Moffitt logo

COVID-19 Safety Precautions: Find the Latest Visitor and Mask Policies. Learn More

Clinical Trials Search

Clinical Trial 20493

Cancer Type: Immunotherapy
Study Type: Treatment
NCT#: NCT03960840

Phase: Phase I
Prinicipal Investigator: Javier Pinilla-Ibarz

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

Phase I, Open Label, Multicenter, Dose Escalation Study of YTB323 in Adult Patients with CLL/SLL and DLBCL

Summary

Objective

Treatments

Therapies

Medications

748645 (Ibrutinib); Ibrutinib (Imbruvica); PCI-32765 (Ibrutinib); YTB323 ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

;